{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T16:24:44Z","timestamp":1787847884987,"version":"build-2784847793"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:00:00Z","timestamp":1787788800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012752","name":"Elanco Animal Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      <jats:italic>Ixodes scapularis<\/jats:italic>\n                      is a consequential tick species in North America that can transmit multiple pathogens of canine and public health significance. Acaricidal speed is critical for reducing the risk of pathogen transmission. Herein, the immediate and sustained acaricidal speed of three monthly oral endectocide products against\n                      <jats:italic>I. scapularis<\/jats:italic>\n                      are compared.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Thirty-two dogs were randomly allocated equally among four groups and treated on day 0 with an endectocide containing lotilaner (Credelio Quattro\u2122), afoxolaner (NexGard\n                      <jats:bold>\u00ae<\/jats:bold>\n                      PLUS) or sarolaner (Simparica Trio\u2122), or left untreated. On days \u22122, 21, and 28, dogs were infested with 50 laboratory-reared, adult\n                      <jats:italic>I. scapularis<\/jats:italic>\n                      . Live tick counts were performed at 4, 8, 12, 24, and 48-h post-treatment, and after each reinfestation. Efficacy was compared using a linear mixed model of geometric mean live tick counts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>At 8-h post-treatment of an existing infestation, only the lotilaner group had significantly lower mean live tick counts than the untreated group. At each subsequent assessment through 48 h, all treated groups had significantly lower mean live tick counts than the untreated group. Compared to the untreated group, following the day 21 reinfestation, mean live tick counts were significantly lower in the lotilaner group at 4 through 48 h, in the sarolaner group at 4, 24, and 48 h, and in the afoxolaner group at 24 and 48 h. Compared to the untreated group, following the day 28 reinfestation, mean live tick counts were significantly lower in the lotilaner group at 8 through 48 h, in the sarolaner group at 12 through 48 h and, in the afoxolaner group at 24 and 48\u00a0h. Within group, between day 0 and day 28, significant slowing of acaricidal speed was observed for sarolaner at the 12-h timepoint and for afoxolaner at the 8, 12, and 24-h timepoints. No significant loss of acaricidal speed occurred for lotilaner between day 0 and day 28.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      In dogs, lotilaner has a faster onset of acaricidal activity against\n                      <jats:italic>I. scapularis<\/jats:italic>\n                      than sarolaner or afoxolaner. Lotilaner\u2019s acaricidal speed is sustained throughout the monthly dosing interval, whereas sarolaner and afoxolaner show slower acaricidal activity at the end of the month than at the beginning.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-026-07559-y","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:22:48Z","timestamp":1784265768000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative speed of kill of induced Ixodes scapularis infestations following treatment of dogs with endectocides containing either sarolaner (Simparica Trio\u2122), afoxolaner (NexGard\u00ae PLUS), or lotilaner (Credelio Quattro\u2122)"],"prefix":"10.1186","volume":"19","author":[{"given":"Kathryn E.","family":"Reif","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Kollasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey L.","family":"Locklear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Eberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayla N.","family":"Braswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia M. W.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian H.","family":"Herrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas P.","family":"McAbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carter M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Grace","family":"Morrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailey J.","family":"Sperling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"7559_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.pt.2017.12.006","volume":"34","author":"RJ Eisen","year":"2018","unstructured":"Eisen RJ, Eisen L. The blacklegged tick, Ixodes scapularis: an increasing public health concern. Trends Parasitol. 2018;34:295\u2013309.","journal-title":"Trends Parasitol"},{"key":"7559_CR2","doi-asserted-by":"publisher","DOI":"10.1093\/jme\/tjaf169","author":"N Bai","year":"2025","unstructured":"Bai N, Eleftheriou A, Pesapane R. Pathogen and host associations of Ixodes scapularis (Acari: Ixodidae) in eastern Ohio 10 years post establishment. J Med Entomol. 2026; 63(1):tjaf169. https:\/\/doi.org\/10.1093\/jme\/tjaf169.","journal-title":"J Med Entomol"},{"key":"7559_CR3","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-ento-121423-013702","author":"MA Diuk-Wasser","year":"2025","unstructured":"Diuk-Wasser MA, Fernandez P, Vanwambeke SO. Tick-borne diseases in urban and periurban areas: a blind spot in research and public health. Annu Rev Entomol. 2026; 71(1):516-634. https:\/\/doi.org\/10.1146\/annurev-ento-121423-013702.","journal-title":"Annu Rev Entomol"},{"key":"7559_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15030478","volume":"15","author":"DE Sonenshine","year":"2018","unstructured":"Sonenshine DE. Range expansion of tick disease vectors in North America: implications for spread of tick-borne disease. Int J Environ Res Public Health. 2018;15:478.","journal-title":"Int J Environ Res Public Health"},{"key":"7559_CR5","unstructured":"Centers for Disease Control (CDC). Lyme disease surveillance data https:\/\/www.cdc.gov\/lyme\/data-research\/facts-stats\/surveillance-data-1.html. Accessed 15 Jan 2026."},{"key":"7559_CR6","unstructured":"Centers for Disease Control (CDC). Anaplasmosis. Epidemiology and statistics. https:\/\/www.cdc.gov\/anaplasmosis\/hcp\/statistics\/index.html Accessed 14 Jan 2026."},{"key":"7559_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.00807-23","volume":"63","author":"KG Rodino","year":"2025","unstructured":"Rodino KG, Theel ES, Pritt BS. Update on North American tick-borne diseases and how to diagnose them. J Clin Microbiol. 2025;63:e0080723.","journal-title":"J Clin Microbiol"},{"key":"7559_CR8","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/j.ttbdis.2018.07.009","volume":"9","author":"TL Johnson","year":"2018","unstructured":"Johnson TL, Graham CB, Maes SE, Hojgaard A, Fleshman A, Boegler KA, et al. Prevalence and distribution of seven human pathogens in host-seeking Ixodes scapularis (Acari: Ixodidae) nymphs in Minnesota, USA. Ticks Tick Borne Dis. 2018;9:1499\u2013507.","journal-title":"Ticks Tick Borne Dis"},{"key":"7559_CR9","doi-asserted-by":"publisher","DOI":"10.4081\/gh.2019.750","author":"Y Liu","year":"2019","unstructured":"Liu Y, Nordone SK, Yabsley MJ, Lund RB, McMahan CS, Gettings JR. Quantifying the relationship between human Lyme disease and Borrelia burgdorferi exposure in domestic dogs. Geospat Health. 2019;\n14(1). https:\/\/doi.org\/10.4081\/gh.2019.750.","journal-title":"Geospat Health"},{"key":"7559_CR10","unstructured":"FDA NADA 141-521. Simparica Trio, Prescribing Information."},{"key":"7559_CR11","unstructured":"FDA NADA 141-554. NexGard PLUS, Prescribing Information."},{"key":"7559_CR12","unstructured":"FDA NADA 141-581. Credelio Quattro, Prescribing Information."},{"key":"7559_CR13","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13071-016-1376-x","volume":"9","author":"C Becskei","year":"2016","unstructured":"Becskei C, Geurden T, Liebenberg J, Cuppens O, Mahabir SP, Six RH. Comparative speed of kill of oral treatments with Simparica\u2122 (sarolaner) and Bravecto\u00ae(fluralaner) against induced infestations of Rhipicephalus sanguineus on dogs. Parasit Vectors. 2016;9:103.","journal-title":"Parasit Vectors"},{"key":"7559_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s13071-017-2024-9","volume":"10","author":"R Packianathan","year":"2017","unstructured":"Packianathan R, Hodge A, Bruellke N, Davis K, Maeder S. Comparative speed of kill of sarolaner (Simparica\u00ae) and afoxolaner (NexGard\u00ae) against induced infestations of Ixodes holocyclus on dogs. Parasit Vectors. 2017;10:98.","journal-title":"Parasit Vectors"},{"key":"7559_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13071-020-3953-2","volume":"13","author":"S Holzmer","year":"2020","unstructured":"Holzmer S, Kryda K, Mahabir SP, Everett W. Evaluation of the speed of kill of a novel orally administered combination product containing sarolaner, moxidectin and pyrantel (Simparica Trio\u2122) against induced infestations of Ixodes scapularis on dogs. Parasit Vectors. 2020;13:76.","journal-title":"Parasit Vectors"},{"key":"7559_CR16","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1186\/s13071-023-05946-3","volume":"16","author":"KE Reif","year":"2023","unstructured":"Reif KE, Bickmeier NP, Herrin BH, Dryden MW, Normile DM, Jesudoss Chelladurai JRJ, et al. Comparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto\u00ae Chew (25 mg\/kg fluralaner) or Simparica TRIO\u00ae (1.2 mg\/kg sarolaner, 24 \u00b5g\/kg moxidectin, 5 mg\/kg pyrantel). Parasit Vectors. 2023;16:440.","journal-title":"Parasit Vectors"},{"key":"7559_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13071-024-06600-2","volume":"18","author":"KE Reif","year":"2025","unstructured":"Reif KE, Dryden MW, Normile DM, Kang Q, Herrin BH, Jesudoss Chelladurai JRJ, et al. Comparison of the initial and residual speed of Amblyomma americanum kill on dogs treated with a single dose of Bravecto\u00ae Chew (25 mg\/kg fluralaner) or Simparica TRIO\u00ae (1.2 mg\/kg sarolaner, 24 \u00b5g\/kg moxidectin, 5 mg\/kg pyrantel). Parasit Vectors. 2025;18:112.","journal-title":"Parasit Vectors"},{"key":"7559_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s13071-024-06363-w","volume":"17","author":"KE Reif","year":"2024","unstructured":"Reif KE, Kollasch TM, Neilson JC, Herrin BH, Ryan WG, Bell MC, et al. Comparative speed of kill provided by lotilaner (Credelio\u2122), sarolaner (Simparica Trio\u2122), and afoxolaner (NexGard\u2122) to control Amblyomma americanum infestations on dogs. Parasit Vectors. 2024;17:313.","journal-title":"Parasit Vectors"},{"key":"7559_CR19","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.vetpar.2013.02.003","volume":"194","author":"AA Marchiondo","year":"2013","unstructured":"Marchiondo AA, Holdsworth PA, Fourie LJ, Rugg D, Hellmann K, Snyder DE, et al. World Association for the Advancement of Veterinary Parasitology (WAAVP) second edition: guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestations on dogs and cats. Vet Parasitol. 2013;194:84\u201397.","journal-title":"Vet Parasitol"},{"key":"7559_CR20","unstructured":"US Food and Drug Administration. Good Clinical Practice. https:\/\/www.fda.gov\/about-fda\/center-drug-evaluation-and-research-cder\/good-clinical-practice. Accessed 26 Jan 2026."},{"key":"7559_CR21","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.vetpar.2014.02.021","volume":"201","author":"L Letendre","year":"2014","unstructured":"Letendre L, Huang R, Kvaternick V, Harriman J, Drag M, Soll M. The intravenous and oral pharmacokinetics of afoxolaner used as a monthly chewable antiparasitic for dogs. Vet Parasitol. 2014;201:190\u20137.","journal-title":"Vet Parasitol"},{"key":"7559_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.vetpar.2016.02.019","volume":"222","author":"TL McTier","year":"2016","unstructured":"McTier TL, Chubb N, Curtis MP, Hedges L, Inskeep GA, Knauer CS, et al. Discovery of sarolaner: a novel, orally administered, broad-spectrum, isoxazoline ectoparasiticide for dogs. Vet Parasitol. 2016;222:3\u201311.","journal-title":"Vet Parasitol"},{"key":"7559_CR23","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s13071-017-2475-z","volume":"10","author":"CE Toutain","year":"2017","unstructured":"Toutain CE, Seewald W, Jung M. The intravenous and oral pharmacokinetics of lotilaner in dogs. Parasit Vectors. 2017;10:522.","journal-title":"Parasit Vectors"},{"key":"7559_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jvp.12959","volume":"45","author":"X Zhou","year":"2022","unstructured":"Zhou X, Hohman AE, Hsu WH. Current review of isoxazoline ectoparasiticides used in veterinary medicine. J Vet Pharmacol Ther. 2022;45:1\u201315.","journal-title":"J Vet Pharmacol Ther"},{"key":"7559_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.01722","volume":"9","author":"N Sertour","year":"2018","unstructured":"Sertour N, Cott\u00e9 V, Garnier M, Malandrin L, Ferquel E, Choumet V. Infection kinetics and tropism of Borrelia burgdorferi sensu lato in mouse after natural (via ticks) or artificial (needle) infection depends on the bacterial strain. Front Microbiol. 2018;9:1722.","journal-title":"Front Microbiol"},{"key":"7559_CR26","unstructured":"Companion Animal Parasite Council (CAPC). 2019. https:\/\/capcvet.org\/guidelines\/lyme-disease\/https:\/\/capcvet.org\/guidelines\/ascarid\/. Accessed 16 Jan 2026."},{"key":"7559_CR27","unstructured":"Cornell College of Veterinary Medicine. Canine health topics. Anaplasmosis. https:\/\/www.vet.cornell.edu\/departments-centers-and-institutes\/riney-canine-health-center\/canine-health-topics\/anaplasmosis. Accessed 16 Jan 2026."},{"key":"7559_CR28","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/jcm.25.3.557-558.1987","volume":"25","author":"J Piesman","year":"1987","unstructured":"Piesman J, Mather TN, Sinsky RJ, Spielman A. Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol. 1987;25:557\u20138.","journal-title":"J Clin Microbiol"},{"key":"7559_CR29","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1086\/318818","volume":"183","author":"F des Vignes","year":"2001","unstructured":"des Vignes F, Piesman J, Heffernan R, Schulze TL, Stafford KC 3rd, Fish D. Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs. J Infect Dis. 2001;183:773\u20138.","journal-title":"J Infect Dis"},{"key":"7559_CR30","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1086\/517829","volume":"177","author":"P Katavolos","year":"1998","unstructured":"Katavolos P, Armstrong PM, Dawson JE, Telford SR 3rd. Duration of tick attachment required for transmission of granulocytic ehrlichiosis. J Infect Dis. 1998;177:1422\u20135.","journal-title":"J Infect Dis"},{"key":"7559_CR31","doi-asserted-by":"publisher","first-page":"910","DOI":"10.3390\/microorganisms8060910","volume":"8","author":"D Tahir","year":"2020","unstructured":"Tahir D, Meyer L, Josephus F, Jongegan F, Mather T, Choumet V, et al. Interrupted blood feeding in ticks: causes and consequences. Microorganisms. 2020;8:910.","journal-title":"Microorganisms"},{"key":"7559_CR32","doi-asserted-by":"publisher","first-page":"4145","DOI":"10.1128\/JCM.39.11.4145-4148.2001","volume":"39","author":"J Piesman","year":"2001","unstructured":"Piesman J, Schneider BS, Zeidner NS. Use of quantitative PCR to measure density of Borrelia burgdorferi in the midgut and salivary glands of feeding tick vectors. J Clin Microbiol. 2001;39:4145\u20138.","journal-title":"J Clin Microbiol"},{"key":"7559_CR33","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13071-019-3396-9","volume":"12","author":"JJ Fourie","year":"2019","unstructured":"Fourie JJ, Evans A, Labuschagne M, Crafford D, Madder M, Pollmeier M, et al. Transmission of Anaplasma phagocytophilum (Foggie, 1949) by Ixodes ricinus (Linnaeus, 1758) ticks feeding on dogs and artificial membranes. Parasit Vectors. 2019;12:136.","journal-title":"Parasit Vectors"},{"key":"7559_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.vetpar.2016.02.010","volume":"222","author":"NA Honsberger","year":"2016","unstructured":"Honsberger NA, Six RH, Heinz TJ, Weber A, Mahabir SP, Berg TC. Efficacy of sarolaner in the prevention of Borrelia burgdorferi and Anaplasma phagocytophilum transmission from infected Ixodes scapularis to dogs. Vet Parasitol. 2016;222:67\u201372.","journal-title":"Vet Parasitol"},{"key":"7559_CR35","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s13071-025-06753-8","volume":"18","author":"J Prullage","year":"2025","unstructured":"Prullage J, Dumont P, Nair A, Liu M, DiCosty U, S\u00fcssenberger R. The ability of an oral combination of afoxolaner, moxidectin and pyrantel to protect dogs from Borrelia burgdorferi infections transmitted by Ixodes scapularis. Parasit Vectors. 2025;18:147.","journal-title":"Parasit Vectors"},{"key":"7559_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13071-025-07136-9","volume":"19","author":"W Anderson","year":"2025","unstructured":"Anderson W, Savadelis MD, Wiseman S, Mansour A, Maree R, Young L. Efficacy of Credelio Quattro\u2122 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) and Credelio\u2122 (lotilaner) chewable tablets in the prevention of Borrelia burgdorferi transmission from infected Ixodes scapularis in dogs. Parasit Vectors. 2025;19:23.","journal-title":"Parasit Vectors"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-026-07559-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07559-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-026-07559-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T15:48:36Z","timestamp":1787845716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-026-07559-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7559"],"URL":"https:\/\/doi.org\/10.1186\/s13071-026-07559-y","relation":{},"ISSN":["1756-3305"],"issn-type":[{"value":"1756-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"17 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Study dogs were handled in compliance with the Auburn University institutional Animal Care and Use Committee approval (IACUC# 2025-5686).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.E.R. and B.H.H. are paid consultants for several animal health companies including Elanco Animal Health and Boehringer Ingelheim. T.M.K, C.L.L., and M.D.E. are employees of Elanco Animal Health. W.G.R. is a paid consultant for Elanco Animal Health. The other authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"368"}}